Improved protein arrays for quantitative systems analysis of the dynamics of signaling pathway interactions

Proteome Science

Volumn 9, Issue , 2011, Pages

  Wang, Xiaoyu ^a,b   Dong, Ying ^a,b   Jiwani, Ameena J ^a,b,c   Zou, Yonglong ^a,b   Pastor, Johanne ^b   Kuro O, Makoto ^a,b   Habib, Amyn A ^a,b,c   Ruan, Minzi ^d   Boothman, David A ^a,b   Yang, Chin Rang ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA North Texas Health Care System   (United States)

^d VigeneTech Inc   (United States)

Author keywords

Analysis; Cross talkimage; Glioma; Protein array; Quantitative analysis; quantum dot; Signaling pathway; Systems biology

Indexed keywords

QUANTUM DOT;

ARTICLE; COMPUTER PROGRAM; CONFOCAL LASER MICROSCOPY; IMAGE ANALYSIS; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEOMICS; WESTERN BLOTTING;

EID: 80052863559     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-9-53     Document Type: Article

References (22)

1. Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003, 3:317-325. 10.1016/S1535-6108(03)00086-2, 12726858.
2. Spurrier B, Ramalingam S, Nishizuka S. Reverse-phase protein lysate microarrays for cell signaling analysis. Nat Protoc 2008, 3:1796-1808. 10.1038/nprot.2008.179, 18974738.
3. Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M, Coombes KR, Mills GB. Functional proteomic profiling of AML predicts response and survival. Blood 2009, 113:154-164. 10.1182/blood-2007-10-119438, 2951831, 18840713.
4. Brase JC, Mannsperger H, Frohlich H, Gade S, Schmidt C, Wiemann S, Beissbarth T, Schlomm T, Sultmann H, Korf U. Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification. Proteome Sci 8:36.
5. Shingyoji M, Gerion D, Pinkel D, Gray JW, Chen F. Quantum dots-based reverse phase protein microarray. Talanta 2005, 67:472-478. 10.1016/j.talanta.2005.06.064, 18970191.
6. Geho D, Lahar N, Gurnani P, Huebschman M, Herrmann P, Espina V, Shi A, Wulfkuhle J, Garner H, Petricoin E, et al. Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjug Chem 2005, 16:559-566. 10.1021/bc0497113, 15898722.
7. Sheehan KM, Calvert VS, Kay EW, Lu Y, Fishman D, Espina V, Aquino J, Speer R, Araujo R, Mills GB, et al. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 2005, 4:346-355. 10.1074/mcp.T500003-MCP200, 15671044.
8. Sheehan KM, Gulmann C, Eichler GS, Weinstein JN, Barrett HL, Kay EW, Conroy RM, Liotta LA, Petricoin EF. Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene 2008, 27:323-331. 10.1038/sj.onc.1210647, 17621268.
9. VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, et al. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 2008, 7:1902-1924. 10.1074/mcp.M800204-MCP200, 2559935, 18687633.
10. Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, Petricoin EF. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003, 3:2085-2090. 10.1002/pmic.200300591, 14595806.
11. Loebke C, Sueltmann H, Schmidt C, Henjes F, Wiemann S, Poustka A, Korf U. Infrared-based protein detection arrays for quantitative proteomics. Proteomics 2007, 7:558-564. 10.1002/pmic.200600757, 17309101.
12. Hatanpaa KJ, Burma S, Zhao D, Habib AA. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 2010, 12:675-684. 2933688, 20824044.
13. Ruan M. Protein Microarray Image Analysis. Functional Protein Microarrays in Drug Discovery 2006, 359. CRC Press, Predki PF, 1.
14. Hu J, He X, Baggerly KA, Coombes KR, Hennessy BT, Mills GB. Non-parametric quantification of protein lysate arrays. Bioinformatics 2007, 23:1986-1994. 10.1093/bioinformatics/btm283, 17599930.
15. Li L, Dutra A, Pak E, Labrie JE, Gerstein RM, Pandolfi PP, Recht LD, Ross AH. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol 2009, 11:9-21. 2718963, 18812521.
16. C VS, Babar SM, Song EJ, Oh E, Yoo YS. Kinetic analysis of the MAPK and PI3K/Akt signaling pathways. Mol Cells 2008, 25:397-406.
17. Andersen P, Villingshoj M, Poulsen HS, Stockhausen MT. Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells. Cancer Invest 2009, 27:178-183. 10.1080/07357900802570759, 19235590.
18. Bromann PA, Korkaya H, Courtneidge SA. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 2004, 23:7957-7968. 10.1038/sj.onc.1208079, 15489913.
19. Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR, Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ. Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene 2002, 21:5038-5046. 10.1038/sj.onc.1205593, 12140754.
20. Antonyak MA, Moscatello DK, Wong AJ. Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem 1998, 273:2817-2822. 10.1074/jbc.273.5.2817, 9446590.
21. Aikin R, Maysinger D, Rosenberg L. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 2004, 145:4522-4531. 10.1210/en.2004-0488, 15242986.
22. Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, et al. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res 2006, 66:867-874. 10.1158/0008-5472.CAN-05-2753, 16424019.